Royal Bank of Canada
INBS icon

Royal Bank of Canada’s Intelligent Bio Solutions INBS Stock Holding History

Royal Bank of Canada’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed – – 7061
2024
Q3 		$0 Buy
+6
New +$94 ﹤0.01% 7114

Other funds holding INBS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada's INBS Position: Q4 2024 in Review

Royal Bank of Canada sold out of Intelligent Bio Solutions (INBS) in Q4 2024, closing a stake of 6 shares.

Royal Bank of Canada first reported a position in INBS in Q3 2024 and held it in 1 quarter. The position peaked at $0 in Q3 2024. 8 funds tracked by Wall St. Rank hold INBS as of Q4 2024.

  • Royal Bank of Canada reported no remaining Intelligent Bio Solutions position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 6 Intelligent Bio Solutions shares in Q4 2024.
  • Royal Bank of Canada first reported a position in Intelligent Bio Solutions in Q3 2024 and held it in 1 quarter.
  • Royal Bank of Canada's Intelligent Bio Solutions position peaked at $0 in Q3 2024.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.